SciELO - Scientific Electronic Library Online

 
vol.62 issue1Genesis and Evolution of Hip ArthroplastySpasticity author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Universitas Medica

Print version ISSN 0041-9095On-line version ISSN 2011-0839

Abstract

BERACASA CARO, Lorena; PARDO BARON, Carlos Andrés  and  SANCHEZ, Jesús Oswaldo. Treatment-Related Toxicity for Cancer in Older Adults. Literature review. Univ. Med. [online]. 2021, vol.62, n.1, pp.68-85.  Epub Jan 15, 2021. ISSN 0041-9095.  https://doi.org/10.11144/javeriana.umed62-1.toxi.

Pathologies of tumor origin are more frequent in the older adult population, however said population has fewer opportunities to access diagnostic studies and therapeutic interventions, not only due to the age and stage of the cancer, but also because they have conditions of aging such as decreased functional reserve, multiple pathologies, cognitive disorders, or lack of social support that impact on the clinical response to the different therapies that exist to treat cancer. In addition to this, the risk of toxicity conferred by the various cancer treatments, which leads to a more careful evaluation of the type of therapy, the dose, and the benefit of starting it. With the discovery of new therapies for cancer management, we not only face the risk of toxicity with traditional chemotherapy, but also the schemes developed in recent times, such as immunotherapy or targeted therapy, which can mainly generate toxicity to a lesser degree. cardiovascular, gastrointestinal and skin hematological. Taking into account the above, an attempt has been made to advance in the prediction of the risk of toxicity to chemo-radiotherapy, counting to date with different models based on clinical and paraclinical calculations, many of these criteria that come out of these tools are derived from the assessment geriatric (GV), we find tools to evaluate functional performance, cognitive status, social support, which provides valuable and comprehensive information for decision-making not only therapeutic, as well as models that include clinical and paraclinical parameters such as the CRASH tool which predicts non-hematological and joint hematological toxicity and the CARG tool that predicts joint toxicity. However, globally, these toxicity risk prediction tools have several limitations, such as the lack of precision when calculating the risk of severe toxicity associated with chemo-radiotherapy, many are not validated, so many studies conclude that models are needed more accurate when predicting such risk. However, it has been shown that combining various tools (functional and clinical) improves results on many occasions by modifying the care plan for the elderly patient with cancer.

Keywords : elderly; cancer; chemotherapy; toxicity.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )